发明名称 JAK2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer
摘要 The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of JAK2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.
申请公布号 US8673933(B2) 申请公布日期 2014.03.18
申请号 US201213459742 申请日期 2012.04.30
申请人 PURANDARE ASHOK V.;GREBINSKI JAMES W.;HART AMY C.;INGHRIM JENNIFER;SCHROEDER GRETCHEN M.;WAN HONGHE;BRISTOL-MYERS SQUIBB COMPANY 发明人 PURANDARE ASHOK V.;GREBINSKI JAMES W.;HART AMY C.;INGHRIM JENNIFER;SCHROEDER GRETCHEN M.;WAN HONGHE
分类号 A61K31/437;C07D487/14 主分类号 A61K31/437
代理机构 代理人
主权项
地址